A Phase II Trial of PS-341 in Patients With Renal Cell Cancer
Phase of Trial: Phase II
Latest Information Update: 17 Dec 2012
At a glance
- Drugs Bortezomib (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 01 Mar 2006 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Oct 2005 New trial record.